Disease-specific serum free fatty acids ( FFAs ) were quantified using chip-based direct-infusion nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry ( CBDInanoESI-FTICR MS ) in the negative ion mode .